Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Gen Intern Med ; 38(16): 3633-3635, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37758968

RESUMO

We describe a case of severe odynophagia and dysphagia caused by dry scooping of multi-ingredient pre-workout powder (MIPS) with diffuse esophageal ulcerations on upper endoscopy. Dry scooping refers to ingesting work out supplements without the recommended doses of solvent. This trend has been the subject of TikTok and other social media sites aimed at enhancing workout performance. While caustic ingestions leading to esophageal ulcers and strictures are well known, dry scooping ingestion of pre-workout powder as an etiology has not been described. Though caffeine may be the predominant content in such powders, the exact composition and ratios of other constituents, including amino acids, are less clear. Complete abstinence from ingestion of the pre-workout formulation and the use of a proton pump inhibitor therapy led to significant clinical and endoscopic recovery over a 4-week period. A thorough history of ingestions, including supplements, is critical when unraveling emerging etiologies of esophageal ulcerations.


Assuntos
Mídias Sociais , Humanos , Pós , Suplementos Nutricionais , Cafeína/farmacologia , Aminas
4.
Artigo em Inglês | MEDLINE | ID: mdl-35548477

RESUMO

Subepithelial lesions are often detected incidentally in patients undergoing an endoscopy. They are common tumors of the gastrointestinal (GI) tract which can originate from different layers of the GI tract wall. These lesions can be further classified based on GI layer of origin and unique histochemical staining. While most are benign and asymptomatic, some of these lesions have malignant potential with distant metastases. However, current diagnostic modalities including endoscopy with biopsy or endoscopic ultrasound with fine needle aspiration are not always reliable. In addition, management of these lesions has historically involved surgical resection via open or laparoscopic approaches. In recent years, with advancement in endoscopic techniques and improvement in endoscopists' skills, less invasive procedures such as endoscopic submucosal dissection (ESD), endoscopic full thickness resection (EFTR) and submucosal tunneling endoscopic resection (STER) have been developed and now are being used by endoscopists worldwide. Upon reviewing the literature, multiple studies have shown the advantages of these endoscopic techniques when compared with surgical treatment. As a result, there has been a dramatic shift towards minimally invasive endoscopic procedures for the management of these subepithelial lesions. In this review article, we will discuss these endoscopic resection techniques in detail, their safety and efficacy, as well as comparison studies to other therapeutic modalities.

5.
World J Gastroenterol ; 27(46): 7969-7981, 2021 Dec 14.
Artigo em Inglês | MEDLINE | ID: mdl-35046624

RESUMO

The coronavirus disease 2019 (COVID-19) has caused one of the worst public health crises in modern history. Even though severe acute respiratory syndrome coronavirus 2 primarily affects the respiratory tract, gastrointestinal manifestations are well described in literature. This review will discuss the epidemiology, virology, manifestations, immunosuppressant states, and lessons learned from COVID-19. Observations: At the time of writing, COVID-19 had infected more than 111 million people and caused over 2.5 million deaths worldwide. Multiple medical comorbidities including obesity, pre-existing liver condition and the use of proton pump inhibitor have been described as risk factor for severe COVID-19. COVID-19 most frequently causes diarrhea (12.4%), nausea/vomiting (9%) and elevation in liver enzymes (15%-20%). The current data does not suggest that patients on immunomodulators have a significantly increased risk of mortality from COVID-19. The current guidelines from American Gastroenterological Association and American Association for the Study of Liver Diseases do not recommend pre-emptive changes in patients on immunosuppression if the patients have not been infected with COVID-19. Conclusions and relevance: The COVID-19 pandemic has prompted a change in structure and shape of gastroenterology departmental activities. Endoscopy should be performed only when necessary and with strict protective measures. Online consultations in the form of telehealth services and home drug deliveries have revolutionized the field.


Assuntos
COVID-19 , Gastroenteropatias , Gastroenteropatias/diagnóstico , Gastroenteropatias/epidemiologia , Trato Gastrointestinal , Humanos , Fígado , Pandemias , SARS-CoV-2
6.
J Gastrointest Oncol ; 9(2): 363-376, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29755777

RESUMO

Colorectal cancer incidence and death rates have been declining over the past 10 years. However, it remains the second leading cause of death in men ages 60-79 and the third leading cause of death in men over 80 and in women over 60 years old. However, there is little data specific to the treatment of the elder patient, since few of these patients are included in trials. With the advent of improved therapies, there are many alternative options available. Still, no definitive consensus or guidelines have been defined for this particular patient population. The goal of this study is to review the literature on the management of rectal cancer in the elderly and to propose treatment algorithms to help the oncology team in treatment decision-making.

7.
World J Gastroenterol ; 23(2): 373-376, 2017 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-28127211

RESUMO

Posterior reversible encephalopathy syndrome (PRES) is a neuro-radiologic diagnosis that has become more widely recognized and reported over the past few decades. As such, there are a number of known risk factors that contribute to the development of this syndrome, including volatile blood pressures, renal failure, cytotoxic drugs, autoimmune disorders, pre-eclampsia, and eclampsia. This report documents the first reported case of PRES in a patient with severe alcoholic hepatitis with hepatic encephalopathy and delves into a molecular pathophysiology of the syndrome.


Assuntos
Encéfalo/diagnóstico por imagem , Encefalopatia Hepática/complicações , Hepatite Alcoólica/complicações , Síndrome da Leucoencefalopatia Posterior/complicações , Síndrome da Leucoencefalopatia Posterior/diagnóstico , Acetamidas/uso terapêutico , Adulto , Anticonvulsivantes/uso terapêutico , Ascite/sangue , Ascite/tratamento farmacológico , Ascite/etiologia , Eletroencefalografia , Feminino , Fármacos Gastrointestinais , Encefalopatia Hepática/sangue , Encefalopatia Hepática/tratamento farmacológico , Hepatite Alcoólica/sangue , Hepatite Alcoólica/tratamento farmacológico , Humanos , Lacosamida , Lactulose/uso terapêutico , Testes de Função Hepática , Imageamento por Ressonância Magnética , Cooperação do Paciente , Síndrome da Leucoencefalopatia Posterior/sangue , Gravidez , Radiografia , Rifamicinas/uso terapêutico , Rifaximina , Convulsões/tratamento farmacológico , Convulsões/etiologia , Albumina Sérica/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA